These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 1833245)

  • 1. Medical treatment of endometriosis: a comparison of the suppressive effects of danazol and nafarelin on reproductive hormones.
    Hickok LR; Burry KA; Cohen NL; Moore DE; Dahl KD; Soules MR
    Fertil Steril; 1991 Oct; 56(4):622-7. PubMed ID: 1833245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative treatment trial of endometriosis using the gonadotrophin-releasing hormone agonist, nafarelin, and the synthetic steroid, danazol.
    Fraser IS; Shearman RP; Jansen RP; Sutherland PD
    Aust N Z J Obstet Gynaecol; 1991 May; 31(2):158-63. PubMed ID: 1834049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Administration of nasal nafarelin as compared with oral danazol for endometriosis. A multicenter double-blind comparative clinical trial.
    Henzl MR; Corson SL; Moghissi K; Buttram VC; Berqvist C; Jacobson J
    N Engl J Med; 1988 Feb; 318(8):485-9. PubMed ID: 2963213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the origin and significance of serum CA-125 concentrations in 97 patients with endometriosis before, during, and after buserelin acetate, nafarelin, or danazol.
    Franssen AM; van der Heijden PF; Thomas CM; Doesburg WH; Willemsen WN; Rolland R
    Fertil Steril; 1992 May; 57(5):974-9. PubMed ID: 1533376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The hypothalamic-pituitary-ovarian axis in patients with endometriosis is suppressed by leuprolide acetate but not by danazol.
    Sakata M; Ohtsuka S; Kurachi H; Miyake A; Terakawa N; Tanizawa O
    Fertil Steril; 1994 Mar; 61(3):432-7. PubMed ID: 8137962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, prospective comparison of endocrine changes induced with intranasal leuprolide or danazol for treatment of endometriosis.
    Tummon IS; Pepping ME; Binor Z; Radwanska E; Dmowski WP
    Fertil Steril; 1989 Mar; 51(3):390-4. PubMed ID: 2522062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nafarelin for endometriosis: a large-scale, danazol-controlled trial of efficacy and safety, with 1-year follow-up. The Nafarelin European Endometriosis Trial Group (NEET).
    Fertil Steril; 1992 Mar; 57(3):514-22. PubMed ID: 1531464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of endometriosis with a potent agonist of gonadotropin-releasing hormone (nafarelin).
    Schriock E; Monroe SE; Henzl M; Jaffe RB
    Fertil Steril; 1985 Nov; 44(5):583-8. PubMed ID: 2932349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of nafarelin versus danazol on lipids and calcium metabolism.
    Bergquist C
    Am J Obstet Gynecol; 1990 Feb; 162(2):589-91. PubMed ID: 2137977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of nafarelin in the treatment of endometriosis.
    Henzl MR; Kwei L
    Am J Obstet Gynecol; 1990 Feb; 162(2):570-4. PubMed ID: 2137971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nafarelin versus danazol in the treatment of endometriosis.
    Rolland R; van der Heijden PF
    Am J Obstet Gynecol; 1990 Feb; 162(2):586-8. PubMed ID: 2137976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic changes during medical treatment of endometriosis: nafarelin acetate versus danazol.
    Burry KA; Patton PE; Illingworth DR
    Am J Obstet Gynecol; 1989 Jun; 160(6):1454-9; discussion 1459-61. PubMed ID: 2525337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between the effects of nafarelin and danazol on serum lipids and lipoproteins in patients with endometriosis.
    Välimäki M; Nilsson CG; Roine R; Ylikorkala O
    J Clin Endocrinol Metab; 1989 Dec; 69(6):1097-103. PubMed ID: 2531153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of nafarelin and danazol on vertebral trabecular bone mass in patients with endometriosis.
    Whitehouse RW; Adams JE; Bancroft K; Vaughan-Williams CA; Elstein M
    Clin Endocrinol (Oxf); 1990 Sep; 33(3):365-73. PubMed ID: 2147597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacologic management of endometriosis.
    Saltiel E; Garabedian-Ruffalo SM
    Clin Pharm; 1991 Jul; 10(7):518-31. PubMed ID: 1830521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of nafarelin acetate and danazol in the treatment of endometriosis.
    Kennedy SH; Williams IA; Brodribb J; Barlow DH; Shaw RW
    Fertil Steril; 1990 Jun; 53(6):998-1003. PubMed ID: 2140996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LRF and TRF test during long-term danazol treatment: increase of the LH and FSH responses but decrease of the prolactin and TSH responses.
    Leppäluoto J; Rönnberg L; Ylöstalo P
    Acta Endocrinol (Copenh); 1983 Sep; 104(1):1-5. PubMed ID: 6414205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nafarelin: a new medical therapy for endometriosis.
    Henzl MR; Monroe SE
    Prog Clin Biol Res; 1990; 323():343-55. PubMed ID: 2137620
    [No Abstract]   [Full Text] [Related]  

  • 19. Nafarelin acetate: a gonadotropin-releasing hormone agonist for the treatment of endometriosis.
    Letassy NA; Thompson DF; Britton ML; Suda RR
    DICP; 1990 Dec; 24(12):1204-9. PubMed ID: 2151003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The rapid ovarian secretory response to pituitary stimulation by the gonadotropin-releasing hormone agonist nafarelin in sexual precocity.
    Rosenfield RL; Garibaldi LR; Moll GW; Watson AC; Burstein S
    J Clin Endocrinol Metab; 1986 Dec; 63(6):1386-9. PubMed ID: 2946712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.